Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
Core Molding Technologies
CMT
$202M
| $10K | ﹤0.01% |
662
+429
| +184% | +$5.56K |
|
4577
Cocrystal Pharma
COCP
$11.3M
| $10K | ﹤0.01% |
638
-737
| -54% | -$11.2K |
|
4578
Citizens Community Bancorp
CZWI
$212M
| $10K | ﹤0.01% |
+746
| New | +$10.1K |
|
|
DHY
4579
Credit Suisse High Yield Credit Fund
DHY
$242M
| $10K | ﹤0.01% |
4,000
| – | – |
|
4580
Vaalco Energy
EGY
$570M
| $10K | ﹤0.01% |
3,133
-21,561
| -87% | -$59.3K |
|
4581
Geospace Technologies
GEOS
$94.6M
| $10K | ﹤0.01% |
1,257
+902
| +254% | +$7.42K |
|
|
HDSN
4582
Hudson Technologies
HDSN
$254M
| $10K | ﹤0.01% |
+2,961
| New | +$7.13K |
|
4583
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$481M
| $10K | ﹤0.01% |
+137
| New | +$9.55K |
|
4584
Imunon
IMNN
$6.68M
| $10K | ﹤0.01% |
40
-69
| -63% | -$16.3K |
|
4585
Inspired Entertainment
INSE
$184M
| $10K | ﹤0.01% |
810
-117
| -13% | -$1.18K |
|
4586
inTEST
INTT
$155M
| $10K | ﹤0.01% |
+582
| New | +$7.86K |
|
4587
IZEA Worldwide
IZEA
$60.6M
| $10K | ﹤0.01% |
973
-719
| -42% | -$9.44K |
|
4588
Invesco KBW High Dividend Yield Financial ETF
KBWD
$408M
| $10K | ﹤0.01% |
+500
| New | +$10.3K |
|
4589
Lipocine
LPCN
$17.5M
| $10K | ﹤0.01% |
413
-857
| -67% | -$20.2K |
|
4590
Lisata Therapeutics
LSTA
$9.02M
| $10K | ﹤0.01% |
415
+411
| +10,275% | +$9.74K |
|
4591
LSB Industries
LXU
$783M
| $10K | ﹤0.01% |
2,245
+1,481
| +194% | +$7.05K |
|
4592
Medallion Financial
MFIN
$229M
| $10K | ﹤0.01% |
1,151
+608
| +112% | +$5.25K |
|
4593
Everspin Technologies
MRAM
$341M
| $10K | ﹤0.01% |
1,507
-4,482
| -75% | -$25.6K |
|
4594
NextDecade
NEXT
$1.79B
| $10K | ﹤0.01% |
2,394
-26,542
| -92% | -$74.8K |
|
4595
Natural Gas Services Group
NGS
$472M
| $10K | ﹤0.01% |
955
+339
| +55% | +$3.39K |
|
4596
Priority Technology Holdings
PRTH
$535M
| $10K | ﹤0.01% |
1,262
-5,117
| -80% | -$36.8K |
|
4597
Reading International Class A
RDI
$33.2M
| $10K | ﹤0.01% |
1,504
+1,236
| +461% | +$7.82K |
|
4598
Ring Energy
REI
$315M
| $10K | ﹤0.01% |
3,355
+2,637
| +367% | +$6.35K |
|
|
SACH
4599
Sachem Capital Corp
SACH
$39.1M
| $10K | ﹤0.01% |
+1,904
| New | +$9.91K |
|
4600
SEACOR Marine Holdings
SMHI
$256M
| $10K | ﹤0.01% |
2,367
+2,317
| +4,634% | +$10.2K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.